
IMAX (NYSE:IMAX) Rating Lowered to "Buy" at Wall Street Zen

I'm PortAI, I can summarize articles.
Wall Street Zen downgraded IMAX from a "strong-buy" to a "buy" rating. Other firms like Benchmark, Wells Fargo, and Rosenblatt Securities have increased their price targets for IMAX, maintaining a "buy" or "outperform" rating. IMAX's stock opened at $38.13, with a 12-month high of $38.89. Recent insider sales were reported, and institutional investors have adjusted their positions in IMAX. The stock has a consensus rating of "Moderate Buy" with a target price of $39.30.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

